Nancy E. Dempze’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.4M Sell
22,097
-13
-0.1% -$3.03K 2.97% 9
2025
Q4
$4.58M Buy
22,110
+358
+2% +$70.8K 2.38% 15
2025
Q3
$4.03M Sell
21,752
-418
-2% -$71.6K 2.22% 17
2025
Q2
$3.39M Sell
22,170
-454
-2% -$69.8K 1.95% 22
2025
Q1
$3.75M Sell
22,624
-2,462
-10% -$385K 2.25% 18
2024
Q4
$3.63M Sell
25,086
-749
-3% -$116K 2.1% 18
2024
Q3
$4.19M Buy
25,835
+401
+2% +$63.9K 2.34% 15
2024
Q2
$3.72M Buy
25,434
+2,090
+9% +$311K 2.55% 17
2024
Q1
$3.69M Sell
23,344
-109
-0.5% -$17.4K 2.81% 16
2023
Q4
$3.68M Buy
23,453
+158
+0.7% +$24.2K 3.07% 13
2023
Q3
$3.63M Buy
23,295
+155
+0.7% +$25.6K 3.26% 10
2023
Q2
$3.83M Buy
23,140
+758
+3% +$122K 3.28% 9
2023
Q1
$3.47M Buy
22,382
+610
+3% +$98.5K 3.16% 11
2022
Q4
$3.85M Buy
21,772
+569
+3% +$98.2K 3.75% 6
2022
Q3
$3.46M Buy
21,203
+490
+2% +$82.9K 3.69% 4
2022
Q2
$3.68M Sell
20,713
-2,901
-12% -$517K 3.69% 5
2022
Q1
$4.18M Buy
23,614
+888
+4% +$151K 3.06% 10
2021
Q4
$3.89M Buy
22,726
+848
+4% +$139K 2.62% 13
2021
Q3
$3.53M Buy
21,878
+415
+2% +$70.8K 2.77% 10
2021
Q2
$3.54M Sell
21,463
-1,447
-6% -$240K 2.98% 10
2021
Q1
$3.77M Sell
22,910
-402
-2% -$65K 3.33% 10
2020
Q4
$3.67M Buy
23,312
+720
+3% +$106K 3.37% 8
2020
Q3
$3.36M Buy
22,592
+1,685
+8% +$249K 3.41% 6
2020
Q2
$2.94M Buy
20,907
+80
+0.4% +$11.7K 3.28% 9
2020
Q1
$2.73M Buy
20,827
+1,451
+7% +$206K 3.67% 6
2019
Q4
$2.83M Buy
19,376
+570
+3% +$77.3K 3.13% 11
2019
Q3
$2.43M Sell
18,806
-1,445
-7% -$190K 2.94% 15
2019
Q2
$2.82M Sell
20,251
-1,862
-8% -$258K 3.24% 10
2019
Q1
$3.09M Sell
22,113
-415
-2% -$55.6K 3.65% 6
2018
Q4
$2.91M Sell
22,528
-1,043
-4% -$145K 4.04% 3
2018
Q3
$3.26M Sell
23,571
-156
-0.7% -$20.7K 3.65% 6
2018
Q2
$2.88M Buy
23,727
+245
+1% +$30.6K 3.52% 5
2018
Q1
$3.01M Buy
23,482
+60
+0.3% +$8.11K 3.71% 3
2017
Q4
$3.27M Buy
23,422
+2,067
+10% +$288K 3.95% 1
2017
Q3
$2.78M Sell
21,355
-982
-4% -$130K 3.91% 3
2017
Q2
$2.96M Buy
22,337
+412
+2% +$52.6K 4.24% 1
2017
Q1
$2.73M Buy
21,925
+1,048
+5% +$125K 4.18% 1
2016
Q4
$2.41M Buy
20,877
+100
+0.5% +$11.6K 4.22% 2
2016
Q3
$2.45M Buy
20,777
+75
+0.4% +$9.1K 4.3% 1
2016
Q2
$2.51M Buy
20,702
+47
+0.2% +$5.34K 4.47% 1
2016
Q1
$2.23M Buy
20,655
+2,090
+11% +$216K 3.92% 2
2015
Q4
$1.91M Buy
+18,565
New +$1.87M 3.67% 3

Other funds holding JNJ

Nancy E. Dempze's JNJ Position: Q1 2026 in Review

Nancy E. Dempze reduced its Johnson & Johnson (JNJ) stake by 0.06% in Q1 2026, selling an estimated $3.03K and leaving 22,097 shares worth $5.4M. The position accounts for 2.97% of the portfolio, ranked #9.

Nancy E. Dempze first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Nancy E. Dempze held 22,097 shares of Johnson & Johnson worth $5.4M as of Q1 2026.
  • Nancy E. Dempze sold 13 Johnson & Johnson shares in Q1 2026, an estimated $3.03K.
  • Johnson & Johnson made up 2.97% of Nancy E. Dempze's portfolio in Q1 2026, its #9 holding.
  • Nancy E. Dempze first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Nancy E. Dempze's 13F filing for Q1 2026, filed 14 May 2026.